About Us

Stelexis Therapeutics is committed to transforming cancer treatment through the discovery of novel targets aimed at the tumor’s origin. Pre-cancer and cancer stem cells (cancerous stem cells) are a primary cause of cancer progression and relapse, and they’re typically not eliminated by current treatment approaches. Previously, identifying targets on cancerous stem cells was almost impossible due to difficulties isolating, propagating and maintaining clinically relevant stem cells for research. Aided by seminal discoveries at leading academic institutions, the Company has developed a proprietary platform, called TumorOrigin™, which enables unprecedented study of these cells for drug discovery.

Our Approach

The TumorOrigin™ platform is designed to discover novel, druggable targets on cancerous stem cells. Utilizing large banks of patient-derived samples, this proprietary approach isolates, expands and maintains these rare cells. The platform is also capable of overcoming former limitations, such as insufficient cell count and cell survival, which until now impeded this area of cancer research. The Company is advancing two lead candidates targeting cancerous stem cells into clinical development.

Our Programs

Stelexis discovery efforts have led to the identification of two candidates targeting the elimination of cancerous stem cells for AML and solid tumors: STLX1018 and STLX2012.

Team

Lynn Biderman

Associate Director, Drug Discovery

Read More

Bozena Bugaj-Gaweda

Research Scientist

Read More

Lumie Benard

Research Scientist and Lab Manager

Read More

Jiahao Chen

Associate Director TumorOrigin™ Platform

Read More

Alice Tang

Research Scientist

Read More

Zhuoxun Wu

Research Scientist

Read More

Board of Directors

Jason Fuller

Read More

Mark Shtilerman

Read More

Jonathan Ramos

Read More

Uli Steidl

Read More

Derrick Rossi

Read More

Investors

Careers

Stelexis is building a team of experienced professionals that share a common goal: to improve the lives of patients with cancer. We seek to hire dynamic, motivated individuals who are committed to discovering and developing novel oncology therapeutic approaches, and we invite you to reach out for more information here:

Job Listings